Applikon's China plant and future Asian hub up and running
Applikon Biotechnology BV has already made 50 bioreactor systems at a new plant in China, which it plans to expand into its Asian manufacturing HQ.
Archives for March 14, 2014
UCB and Sanofi team to replace biologics with small molecules
UCB and Sanofi have allied to replace current anti-inflammatory biotherapies with small molecule alternatives.
EMD Millipore wins $400K grant from Massachusetts for Promethera partnership
In what may be an early indication of states looking to get more involved in biologic development, EMD Millipore has won a $400,000 grant from the Massachusetts Life Sciences Center (MLSC) to fund a partnership with Promethera Biosciences.
Patheon and DSM fully complementary for biologics post-merger, says DPx Exec
Patheon brings fill/finish capabilities to DSM’s biomanufacturing services, President of Biopharma at the recently merged company DPx told Biopharma-Reporter.com in an exclusive interview.